US Stock MarketDetailed Quotes

CNSP CNS Pharmaceuticals

Watchlist
  • 0.1470
  • -0.0057-3.73%
Close Aug 29 16:00 ET
  • 0.1422
  • -0.0048-3.27%
Pre 04:27 ET
4.73MMarket Cap-1P/E (TTM)

CNS Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments
-65.14%1.49M
-84.05%815.23K
-94.54%548.72K
-94.54%548.72K
-87.06%909.55K
-52.23%4.28M
-58.92%5.11M
100.93%10.06M
100.93%10.06M
-15.60%7.03M
-Cash and cash equivalents
-65.14%1.49M
-84.05%815.23K
-94.54%548.72K
-94.54%548.72K
-87.06%909.55K
-52.23%4.28M
-58.92%5.11M
100.93%10.06M
100.93%10.06M
-15.60%7.03M
Current deferred assets
--16.75K
--0
--202.86K
--202.86K
----
----
----
--0
--0
----
Other current assets
-64.44%637.09K
-57.78%786.05K
-66.54%839.59K
-66.54%839.59K
-31.12%1.15M
-26.52%1.79M
-18.80%1.86M
1.47%2.51M
1.47%2.51M
-40.88%1.67M
Total current assets
-64.66%2.15M
-77.03%1.6M
-87.34%1.59M
-87.34%1.59M
-76.30%2.06M
-46.73%6.07M
-52.68%6.97M
68.03%12.56M
68.03%12.56M
-22.01%8.7M
Non current assets
Net PPE
5.06%3.55K
-1.82%4.31K
-12.91%4.93K
-12.91%4.93K
-59.28%3.47K
-69.17%3.38K
-65.56%4.39K
-64.84%5.66K
-64.84%5.66K
-51.38%8.52K
Non current deferred assets
----
----
----
----
----
----
----
----
----
0.00%334.14K
Non current prepaid assets
-15.08%320.32K
-87.38%55.3K
-78.30%104.75K
-78.30%104.75K
-55.84%262.73K
-46.48%377.2K
-44.67%438.13K
-48.07%482.81K
-48.07%482.81K
--594.9K
Total non current assets
-14.90%323.87K
-86.53%59.6K
-77.55%109.68K
-77.55%109.68K
-71.61%266.2K
-63.75%380.58K
-61.14%442.52K
-61.84%488.47K
-61.84%488.47K
166.61%937.56K
Total assets
-61.73%2.47M
-77.60%1.66M
-86.97%1.7M
-86.97%1.7M
-75.84%2.33M
-48.17%6.45M
-53.28%7.41M
49.05%13.05M
49.05%13.05M
-16.25%9.64M
Liabilities
Current liabilities
Payables
----
----
----
----
300.67%4.03M
627.39%3.57M
467.80%2.78M
----
----
-31.24%1.01M
-accounts payable
----
----
----
----
300.67%4.03M
627.39%3.57M
467.80%2.78M
----
----
-31.24%1.01M
Current accrued expenses
----
----
----
----
----
-5.94%260.14K
177.91%853.23K
----
----
-77.81%200K
Current debt and capital lease obligation
-25.93%123.25K
-26.28%213.1K
-26.63%300.81K
-26.63%300.81K
6.73%41.9K
6.39%166.4K
6.05%289.08K
5.72%409.97K
5.72%409.97K
-12.04%39.26K
-Current debt
-25.93%123.25K
-26.28%213.1K
-26.63%300.81K
-26.63%300.81K
6.73%41.9K
6.39%166.4K
6.05%289.08K
5.72%409.97K
5.72%409.97K
-12.04%39.26K
Current liabilities
69.19%6.76M
55.28%6.09M
24.65%6.13M
24.65%6.13M
226.99%4.07M
332.66%4M
266.87%3.92M
89.66%4.92M
89.66%4.92M
-48.31%1.24M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
69.19%6.76M
55.28%6.09M
24.65%6.13M
24.65%6.13M
226.99%4.07M
332.66%4M
266.87%3.92M
89.66%4.92M
89.66%4.92M
-48.31%1.24M
Shareholders'equity
Share capital
-65.15%1.44K
379.29%10.67K
284.29%6.21K
284.29%6.21K
-89.49%4.21K
-89.66%4.14K
-94.44%2.23K
70.39%1.62K
70.39%1.62K
45.78%40.03K
-common stock
-65.15%1.44K
379.29%10.67K
284.29%6.21K
284.29%6.21K
-89.49%4.21K
-89.66%4.14K
-94.44%2.23K
70.39%1.62K
70.39%1.62K
45.78%40.03K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-26.77%-75.64M
-31.38%-73.11M
-37.17%-69.57M
-37.17%-69.57M
-43.44%-64.19M
-44.36%-59.67M
-47.34%-55.65M
-43.10%-50.72M
-43.10%-50.72M
-39.04%-44.75M
Paid-in capital
14.86%71.35M
16.12%68.67M
10.67%65.13M
10.67%65.13M
17.59%62.45M
17.61%62.12M
12.58%59.14M
41.45%58.85M
41.45%58.85M
28.71%53.11M
Total stockholders'equity
-274.93%-4.29M
-226.88%-4.43M
-154.50%-4.43M
-154.50%-4.43M
-120.74%-1.74M
-78.70%2.45M
-76.41%3.49M
31.96%8.13M
31.96%8.13M
-7.76%8.39M
Total equity
-274.93%-4.29M
-226.88%-4.43M
-154.50%-4.43M
-154.50%-4.43M
-120.74%-1.74M
-78.70%2.45M
-76.41%3.49M
31.96%8.13M
31.96%8.13M
-7.76%8.39M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Assets
Current assets
Cash, cash equivalents and short term investments -65.14%1.49M-84.05%815.23K-94.54%548.72K-94.54%548.72K-87.06%909.55K-52.23%4.28M-58.92%5.11M100.93%10.06M100.93%10.06M-15.60%7.03M
-Cash and cash equivalents -65.14%1.49M-84.05%815.23K-94.54%548.72K-94.54%548.72K-87.06%909.55K-52.23%4.28M-58.92%5.11M100.93%10.06M100.93%10.06M-15.60%7.03M
Current deferred assets --16.75K--0--202.86K--202.86K--------------0--0----
Other current assets -64.44%637.09K-57.78%786.05K-66.54%839.59K-66.54%839.59K-31.12%1.15M-26.52%1.79M-18.80%1.86M1.47%2.51M1.47%2.51M-40.88%1.67M
Total current assets -64.66%2.15M-77.03%1.6M-87.34%1.59M-87.34%1.59M-76.30%2.06M-46.73%6.07M-52.68%6.97M68.03%12.56M68.03%12.56M-22.01%8.7M
Non current assets
Net PPE 5.06%3.55K-1.82%4.31K-12.91%4.93K-12.91%4.93K-59.28%3.47K-69.17%3.38K-65.56%4.39K-64.84%5.66K-64.84%5.66K-51.38%8.52K
Non current deferred assets ------------------------------------0.00%334.14K
Non current prepaid assets -15.08%320.32K-87.38%55.3K-78.30%104.75K-78.30%104.75K-55.84%262.73K-46.48%377.2K-44.67%438.13K-48.07%482.81K-48.07%482.81K--594.9K
Total non current assets -14.90%323.87K-86.53%59.6K-77.55%109.68K-77.55%109.68K-71.61%266.2K-63.75%380.58K-61.14%442.52K-61.84%488.47K-61.84%488.47K166.61%937.56K
Total assets -61.73%2.47M-77.60%1.66M-86.97%1.7M-86.97%1.7M-75.84%2.33M-48.17%6.45M-53.28%7.41M49.05%13.05M49.05%13.05M-16.25%9.64M
Liabilities
Current liabilities
Payables ----------------300.67%4.03M627.39%3.57M467.80%2.78M---------31.24%1.01M
-accounts payable ----------------300.67%4.03M627.39%3.57M467.80%2.78M---------31.24%1.01M
Current accrued expenses ---------------------5.94%260.14K177.91%853.23K---------77.81%200K
Current debt and capital lease obligation -25.93%123.25K-26.28%213.1K-26.63%300.81K-26.63%300.81K6.73%41.9K6.39%166.4K6.05%289.08K5.72%409.97K5.72%409.97K-12.04%39.26K
-Current debt -25.93%123.25K-26.28%213.1K-26.63%300.81K-26.63%300.81K6.73%41.9K6.39%166.4K6.05%289.08K5.72%409.97K5.72%409.97K-12.04%39.26K
Current liabilities 69.19%6.76M55.28%6.09M24.65%6.13M24.65%6.13M226.99%4.07M332.66%4M266.87%3.92M89.66%4.92M89.66%4.92M-48.31%1.24M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 69.19%6.76M55.28%6.09M24.65%6.13M24.65%6.13M226.99%4.07M332.66%4M266.87%3.92M89.66%4.92M89.66%4.92M-48.31%1.24M
Shareholders'equity
Share capital -65.15%1.44K379.29%10.67K284.29%6.21K284.29%6.21K-89.49%4.21K-89.66%4.14K-94.44%2.23K70.39%1.62K70.39%1.62K45.78%40.03K
-common stock -65.15%1.44K379.29%10.67K284.29%6.21K284.29%6.21K-89.49%4.21K-89.66%4.14K-94.44%2.23K70.39%1.62K70.39%1.62K45.78%40.03K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -26.77%-75.64M-31.38%-73.11M-37.17%-69.57M-37.17%-69.57M-43.44%-64.19M-44.36%-59.67M-47.34%-55.65M-43.10%-50.72M-43.10%-50.72M-39.04%-44.75M
Paid-in capital 14.86%71.35M16.12%68.67M10.67%65.13M10.67%65.13M17.59%62.45M17.61%62.12M12.58%59.14M41.45%58.85M41.45%58.85M28.71%53.11M
Total stockholders'equity -274.93%-4.29M-226.88%-4.43M-154.50%-4.43M-154.50%-4.43M-120.74%-1.74M-78.70%2.45M-76.41%3.49M31.96%8.13M31.96%8.13M-7.76%8.39M
Total equity -274.93%-4.29M-226.88%-4.43M-154.50%-4.43M-154.50%-4.43M-120.74%-1.74M-78.70%2.45M-76.41%3.49M31.96%8.13M31.96%8.13M-7.76%8.39M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg